Regorafenib,Nivolumab,Docetaxel,Paclitaxel,Irinotecan,trifluridine tipiracil
Bayer,BMS,Taiho pharma
[]
regorafenib a possible 3rd line in gastro-esophageal adenocarcinoma, interesting results #gi23 
Medical Oncologist

Gastrointestinal Cancer Department 

Hospital Clínic de Barcelona